EyePoint (EYPT) Earnings Date & Reports

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

EYPT is expected to report earnings to fall 4.72% to -94 cents per share on August 05

Q2'26

Est.

$-0.94

Q1'26

Missed

by $0.17

Q4'25

Missed

by $0.06

Q3'25

Missed

by $0.08

Q2'25

Missed

by $0.04

The last earnings report on May 06 showed earnings per share of -99 cents, missing the estimate of -81 cents. With 925.25K shares outstanding, the current market capitalization sits at 987.65M.

View a ticker or compare two or three

Compare

EYPT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EYPT